Top

Tag: vaccines


Industry, Vaccines

COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they’re a double-edged sword for J&J and AZ

January 20, 2022

Via: FiercePharma

Pfizer and Moderna are now two of the leading pharma companies in the U.S. when it comes to public image, thanks to their COVID vaccines. On the flip side, vaccine rivals J&J and AstraZeneca have seen their reputations plummet. This […]


Industry, Vaccines

mRNA COVID-19 vaccines safe for pregnant women, finds EMA review

January 19, 2022

Via: European Pharmaceutical Review

According to the European Medicines Agency (EMA)’s COVID-19 task force (ETF), a growing body of evidence suggests that messenger RNA (mRNA) COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies. The ETF undertook a detailed review […]


Industry, Vaccines

WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased

January 19, 2022

Via: Drugs.com

If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday. However, if wealthier countries don’t share their resources with poorer countries, there will continue to be high […]


Industry, Vaccines

As Omicron Surges, Effort to Vaccinate Young Children Stalls

January 14, 2022

Via: Kaiser Health News

Two months after Pfizer’s covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million […]


Mergers and Acquisitions

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System

January 11, 2022

Via: Biopharm International

Pfizer and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, have entered into a development and option agreement under which Pfizer will have the option to license, on a non-exclusive […]


Cell and Gene Therapy, Industry

Pfizer expands into gene editing with Beam research deal

January 10, 2022

Via: Biopharma Dive

Last summer, Mikael Dolsten, head of research and development at Pfizer and the company’s top scientist, was thinking of new uses for the messenger RNA technology the pharmaceutical giant had developed so effectively for its coronavirus vaccine. The drugmaker already […]


Industry, Vaccines

FDA Shortens Time to Booster After Moderna Vaccine to 5 Months

January 7, 2022

Via: Drugs.com

Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down […]


News

AstraZeneca picks up new weapon in rare disease fight with Alnylam and Pfizer, paying $30M for rights to an early-phase asset

January 7, 2022

Via: FierceBiotech

AstraZeneca is stepping up its pursuit of a rare disease market targeted by Alnylam and Pfizer. Having entered the ATTR space through its takeover of Alexion, AstraZeneca is paying $30 million for worldwide rights to Neurimmune’s NI006 in its second […]


Industry, Vaccines

Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine

January 6, 2022

Via: PMLiVE

The collaboration will see the two companies exploring new R&D and commercialisation in the hope of producing a preventative treatment for shingles – herpes zoster virus (HZV) – which is believed to impact around one in three people in the […]


Industry, Vaccines

Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine

January 5, 2022

Via: World Pharma News

Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today announced a partnership with Dutch Leiden University Medical Center (LUMC) to develop and evaluate a new nasal spray corona vaccine in a […]


Industry, Vaccines

CDC Panel Backs FDA Approval of Boosters for Those Aged 12-15

January 5, 2022

Via: Drugs.com

An advisory panel to the U.S. Centers for Disease Control and Prevention on Wednesday backed the emergency use approval of Pfizer’s booster shots for those between the ages of 12 and 17. The Food and Drug Administration had announced the […]


Industry, Vaccines

COVID-19 tracker: Pfizer-BioNTech booster expands its OK; Johnson & Johnson shot tackles omicron

January 4, 2022

Via: FiercePharma

The FDA further expanded the emergency use authorization for a booster shot of Pfizer-BioNTech’s Comirnaty. Johnson & Johnson’s COVID vaccine showed 85% efficacy against COVID-related hospitalization caused by omicron. The worldwide case count has risen to nearly 293 million Tuesday […]